Is recombinant follicle-stimulating hormone more effective in IVF poor responders than human menopausal gonadotrophins?

Background: The objective of this study was to determine if the recombinant human follicle-stimulating hormone (rFSH) is more effective than human menopausal gonadotrophin (hMG) in IVF poor responders.

Material/methods: A prospective comparative study over a 2-year period. The setting was the Tertiary IVF Center, King Faisal Specialist Hospital and Research Center.